BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 18755270)

  • 1. Quality by design - Spray drying of insulin intended for inhalation.
    Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
    Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray-drying process optimization for manufacture of drug-cyclodextrin complex powder using design of experiments.
    Nekkanti V; Muniyappan T; Karatgi P; Hari MS; Marella S; Pillai R
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1219-29. PubMed ID: 19555246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation.
    Ståhl K; Claesson M; Lilliehorn P; Lindén H; Bäckström K
    Int J Pharm; 2002 Feb; 233(1-2):227-37. PubMed ID: 11897427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process.
    Gonnissen Y; Gonçalves SI; De Geest BG; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 Mar; 68(3):760-70. PubMed ID: 17964129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs.
    Tewa-Tagne P; Degobert G; Briançon S; Bordes C; Gauvrit JY; Lanteri P; Fessi H
    Pharm Res; 2007 Apr; 24(4):650-61. PubMed ID: 17318421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a spray congealing process for the preparation of insulin-loaded lipid microparticles and characterization thereof.
    Maschke A; Becker C; Eyrich D; Kiermaier J; Blunk T; Göpferich A
    Eur J Pharm Biopharm; 2007 Feb; 65(2):175-87. PubMed ID: 17070025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles.
    Kawakami K; Sumitani C; Yoshihashi Y; Yonemochi E; Terada K
    Int J Pharm; 2010 May; 390(2):250-9. PubMed ID: 20170721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimisation of spray drying process conditions for sugar nanoporous microparticles (NPMPs) intended for inhalation.
    Amaro MI; Tajber L; Corrigan OI; Healy AM
    Int J Pharm; 2011 Dec; 421(1):99-109. PubMed ID: 21963473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical modeling of protein spray drying at the lab scale.
    Prinn KB; Costantino HR; Tracy M
    AAPS PharmSciTech; 2002; 3(1):E4. PubMed ID: 12916957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design space approach in the optimization of the spray-drying process.
    Lebrun P; Krier F; Mantanus J; Grohganz H; Yang M; Rozet E; Boulanger B; Evrard B; Rantanen J; Hubert P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):226-34. PubMed ID: 21983606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
    Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ
    Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of in-line spatial filter velocimetry as PAT monitoring tool for particle growth during fluid bed granulation.
    Burggraeve A; Van Den Kerkhof T; Hellings M; Remon JP; Vervaet C; De Beer T
    Eur J Pharm Biopharm; 2010 Sep; 76(1):138-46. PubMed ID: 20554021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclone selection influences protein damage during drying in a mini spray-dryer.
    Bögelein J; Lee G
    Int J Pharm; 2010 Nov; 401(1-2):68-71. PubMed ID: 20887779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by design approach to understand the process of nanosuspension preparation.
    Verma S; Lan Y; Gokhale R; Burgess DJ
    Int J Pharm; 2009 Jul; 377(1-2):185-98. PubMed ID: 19446617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy.
    Lee SH; Heng D; Ng WK; Chan HK; Tan RB
    Int J Pharm; 2011 Jan; 403(1-2):192-200. PubMed ID: 20951781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Ciprofloxacin Hydrochloride Spray-Dried Microparticles for Pulmonary Delivery Using Design of Experiments.
    Razuc M; Piña J; Ramírez-Rigo MV
    AAPS PharmSciTech; 2018 Oct; 19(7):3085-3096. PubMed ID: 30105497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality by design - Spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation.
    Alhajj N; O'Reilly NJ; Cathcart H
    Int J Pharm; 2023 Jul; 642():123151. PubMed ID: 37364778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.